Cherry Creek Investment Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Cherry Creek Investment Advisors's AMGN Position: Q2 2026 in Review
Cherry Creek Investment Advisors increased its Amgen (AMGN) stake by 1.7% in Q2 2026, buying an estimated $4.45K and bringing the position to 772 shares worth $280K. The position accounts for 0.11% of the portfolio, ranked #104.
Cherry Creek Investment Advisors first reported a position in AMGN in Q4 2021 and has held it in 16 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Cherry Creek Investment Advisors held 772 shares of Amgen worth $280K as of Q2 2026.
- Cherry Creek Investment Advisors bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
- Amgen made up 0.11% of Cherry Creek Investment Advisors's portfolio in Q2 2026, its #104 holding.
- Cherry Creek Investment Advisors first reported a position in Amgen in Q4 2021 and has held it in 16 quarters since.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Cherry Creek Investment Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.